Manufacturer record
Aishwarya Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Aishwarya Healthcare (Himachal Pradesh) were declared Not of Standard Quality between July 2020 and March 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AA4009, Bupivacaine Hydrochloride In Dextrose Injection USP (exp Feb 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: Particulate matter (visible) and Description. Listed in the March 2025 alert.
Records by type
6 records linked to Aishwarya Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupivacaine Hydrochloride In Dextrose Injection USP | Batch AA4009Mfg Mar 2024 · Exp Feb 2026 | Particulate matter (visible) and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
| Hepacel 25000 IU/5 ml (Heparin Sodium Injection I.P.) | Batch ATFT2002Mfg Aug 2022 · Exp Jul 2024 | AssayAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Bunase 0.5 Respules (Budesonide Nebuliser Suspension BP) | Batch RS1195Mfg Nov 2021 · Exp Oct 2023 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Mar 2022 |
| LORAZEPAM INJECTION IP | Batch RS1071Mfg Jun 2021 · Exp May 2023 | AssayAssay | RDTL ChandigarhState lab | Sep 2021 |
| Budesonide Nebuliser Suspension BP (BUPICORT 0.5 MG/2 ML) | Batch RS0059Mfg Mar 2020 · Exp Feb 2022 | AssayAssay | RDTL ChandigarhState lab | Sep 2021 |
| (FLUCONAZOLE INJECTION USP 0.2% W/V) | Batch A9123Mfg Apr 2019 · Exp Mar 2021 | Organic ImpuritiesOther | RDTL ChandigarhCDSCO lab | Jul 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.